Diligence memo · auto-generated · as of July 2, 2026
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Afferent Pharmaceuticals, Inc. operates in Other Health Care, based in BOSTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Afferent Pharmaceuticals, Inc. has raised $58M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $55M on 2015-07-01.
Most recent recorded round closed around 2015-07-01.
Valuation (modeled)modeled
Provath models Afferent Pharmaceuticals, Inc. at approximately $1.3B (range $200M–$3.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.10× the median modeled value of Series C Other Health Care companies in 2013–2015 (33 peers) — value vs value, same stage and era. Within the normal band (110% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 34 months.
Last raise 11.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 18.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: ACON IWP Holdings, L.L.C., Erc Group Holdings, Llc, Cpf Senior Living Holdings, Llc, Corvus Pharmaceuticals, Inc., TVG-SHC Holdings, LLC.
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.